Financial Performance - The Group's revenue for the Relevant Period was $6.8 million, a decrease of $0.2 million or 3.3% compared to $7.1 million in the Previous Period[14]. - The Group's profit for the Relevant Period was $173,000, down from a profit of $506,000 in the Previous Period[14]. - Gross profit for the Relevant Period was $2.3 million, compared to $2.5 million in the Previous Period[16]. - The Group's earnings per share for the Relevant Period were 0.02 cents, down from 0.06 cents in the Previous Period[16]. - The total comprehensive income for the period ended March 31, 2025, was $173,000, an increase from $506,000 for the period ended March 31, 2024[18]. - Consolidated profit before taxation for 2025H1 was $267,000, a decline of 55.3% compared to $596,000 in 2024H1[38]. - Segment profit for 2025H1 was $2,304,000, down 11.4% from $2,494,000 in 2024H1[38]. - Total revenue for 2025H1 was $6,837,000, a decrease of 3.25% from $7,067,000 in 2024H1[35]. Expenses and Liabilities - Selling and distribution expenses increased to $1.046 million from $0.914 million in the Previous Period[16]. - Employee costs, including Directors' remuneration, increased to $1.6 million during the Relevant Period, up from $1.3 million in the previous period[100]. - The Group's current taxation for 2025H1 was $94,000, compared to $90,000 in 2024H1[41]. - The Group's total liabilities were $3.3 million as of March 31, 2025, down from $3.6 million as of September 30, 2024[86]. Assets and Equity - Total assets as of March 31, 2025, were $21.695 million, slightly down from $21.785 million as of September 30, 2024[17]. - Total equity attributable to shareholders increased to $18.364 million from $18.191 million[17]. - The total equity of the company increased to $18,364,000 as of March 31, 2025, compared to $17,334,000 as of March 31, 2024, indicating a growth of 5.9%[18]. - Cash and cash equivalents rose to $3.682 million from $3.453 million[17]. - Cash and bank balances at the end of the first half of 2025 were $3,682,000, up from $2,868,000 at the end of the first half of 2024, representing a 28.4% increase[19]. Dividends - The Board has resolved not to declare any dividend for the Relevant Period[14]. - The company has resolved not to declare any dividend for 2025H1, consistent with 2024H1[81]. Business Operations - The Group's principal activity remains the supply of tissue products to corporate customers in Singapore, with a focus on tissue and hygiene-related products[22][28]. - The company remains optimistic about industry growth in Singapore, emphasizing the necessity of tissue products[63][64]. - Major customer Company A contributed $1,142,000 to revenue in 2025H1, down from $1,295,000 in 2024H1[38]. - Sales of hygiene-related products decreased by 14.3%, amounting to a reduction of $64,000[80]. Corporate Governance - The company has adopted and complied with the Corporate Governance Code, with a noted deviation regarding the roles of Chairman and CEO being held by the same individual[135]. - The Audit Committee consists of three independent non-executive Directors, ensuring proper oversight of financial statements[136]. - All Directors confirmed compliance with the Required Standard of Dealings during the Relevant Period[125]. Future Outlook - Future outlook indicates a revenue growth target of 15% for FY2025, driven by new product launches and market expansion strategies[147]. - The company is investing in research and development for innovative technologies, with a budget allocation of HK$50 million for FY2024[148]. - Market expansion plans include entering two new international markets by the end of FY2025, aiming for a 10% market share in each[145]. - A new product line is set to launch in Q1 FY2025, expected to contribute an additional HK$20 million in revenue[147]. - The company aims to improve operational efficiency by 5% through process optimization initiatives in FY2024[148]. Shareholder Information - Mr. Chua Liang Sie holds 552,000,000 shares, representing 69% of the total issued shares of YJH Group Limited[112]. - Mr. Chua Liang Chui holds 552,000,000 shares, also representing 69% of the total issued shares of YJH Group Limited[112]. - YJH Group Limited is approximately 82.76% owned by Mr. Chua Liang Sie and 17.24% by Mr. Chua Liang Chui[113]. Compliance and Regulations - The company has confirmed compliance with the trading standards by all Directors during the relevant period[131]. - The company is committed to ensuring that its business activities and decision-making processes are regulated in a prudent manner[134]. - Forward-looking statements in the report involve known and unknown risks that could cause actual results to differ materially[139].
日光控股(08451) - 2025 - 中期财报